Almaarefa University
The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.

المخرجات

Research outputs

Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.

ReviewOpen access202522citation· Semantic Scholar

Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources

Clinical Cosmetic and Investigational Dermatology · vol. Volume 18 · 2215-2227

Mesenchymal stem cell (MSC)-derived exosomes are recognized a promising cell-free therapy for alopecia. These nano-vesicles facilitate intercellular communication and contain a variety of bioactive molecules that can potentially stimulate hair follicle regeneration. However, the safety and efficacy of exosome therapy for alopecia remains to be determined. This systematic analysis aimed to determine the clinical safety and effectiveness of exosome therapy for hair growth, particularly androgenetic alopecia (AGA) and other forms of hair loss. Systematic searches were conducted on PubMed, Scopus, and Embase databases to find clinical studies published from inception until 10th May 2025 that explored exosome-based interventions for hair loss. Eleven studies included: two RCTs, three retrospective studies, three prospective single-arm studies, one case series, and two case reports. Extracted data included method of preparation, outcomes of hair regrowth (density, thickness, patient satisfaction), and side effects. Quality of evidence was assessed using the Oxford Centre for Evidence-Based Medicine (OCEBM) levels and risk of bias tools (RoB 2 and ROBINS-I). All the studies included demonstrated improvements in at least one hair parameter, with MSC-derived exosomes from adipose tissue, placenta, hair follicles, bone marrow, foreskin, and umbilical cord having substantial increases in hair density (9.5 to 35 hairs/cm²) and hair thickness (up to 13.01 µm). Patient satisfaction was generally high (3-10 point scales), and no serious adverse events were noted. The greatest level of evidence came from RCTs with adipose- and plant extract-derived exosome formulation. However, heterogeneity in design and outcome limited direct comparisons. Exosome therapy, particularly with MSC-derived sources, appears to be a new and safe treatment modality for hair restoration in AGA and other alopecias. The current evidence is, however, limited by heterogeneity in studies, small sample sizes, and varying follow-up durations. More well-standardized, high-quality RCTs are required to confirm these findings and establish standardized treatment protocols.

exosomeshair regrowthhair lossandrogenetic alopecia
ArticleOpen access202522citation· Semantic Scholar

RETRACTED: A review on sustainable non-thermal approaches for pea protein: Pre-treatment, extraction, modification, and applications

Food Chemistry X · vol. 29 · 102608-102608

Pea protein is gaining global attention as a sustainable, plant-based alternative to animal proteins due to its lower environmental impact. However, conventional thermal processing methods can degrade its functional and nutritional properties. This review explores sustainable non-thermal approaches for pea protein processing, focusing on pre-treatment, extraction, and modification. Ultrasonication is the most effective extraction technique and offers higher protein content (82.76 to 85.76%) compared to alkaline, air classification, and enzymatic methods. For protein modification, enzymatic treatment proves most effective, enhancing digestibility by 20.86 to 22.50% and solubility by 64.28 to 66.55%, while preserving structural integrity, compared to other non-thermal techniques. We critically assess the impact of these techniques on protein conformation, allergenicity reduction, and bioavailability and discuss their applications in food formulations and plant-based alternatives. Despite technological advances, significant research gaps remain in understanding molecular structural changes and challenges in industrial scalability. Future studies should focus on scaling processing methods.

pea proteinnon-thermal processingsonicationprotein extraction
ArticleOpen (repository)202522citation· Semantic Scholar

Sum Rate Maximization for 6G Beyond Diagonal RIS-Assisted Multi-Cell Transportation Systems

IEEE Transactions on Intelligent Transportation Systems · vol. 26 (10) · 17601-17611

With the rapid evolution toward data-intensive applications and sustainable urban mobility, upcoming sixth-generation (6G) wireless networks must deliver enhanced coverage, high spectral efficiency, and energy optimization across densely populated areas. However, achieving these requirements poses significant challenges due to the dynamic nature of urban environments, high interference in multi-cell systems, and limitations in conventional passive beamforming technologies. To address these challenges, reconfigurable intelligent surface (RIS) is considered a highly promising approach for enabling and improving 6G wireless communications. This is because it has the ability to efficiently manipulate wireless channels at a lower cost. Considerable study has focused on the utilization of conventional diagonal RIS, in which each individual RIS component is linked to its own ground load but not interconnected with other elements. Nevertheless, the uncomplicated structure of classical RIS imposes restrictions on its ability to manipulate passive beamforming. In this study, we consider beyond diagonal RIS (BD-RIS) in the multi-cell transportation system, which goes beyond using diagonal phase shift matrices. In particular, we provide a new optimization framework to maximize the sum rate of BD-RIS assisted multi-cell transportation system by optimizing the power allocation of the base station and phase shift design of BD-RIS in each cell. We employ the block coordinate descent method to transform the original optimization problem and achieve a local optimal based on standard convex approaches. Numerical results demonstrate the benefits of adopting BD-RIS in multi-cell transportation systems compared to the classical RIS architecture.

beyond-diagonal reconfigurable intelligent surfacesum rate maximization6Gpassive beamforming
ReviewOpen access202519citation· Semantic Scholar

Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review

Cureus · vol. 17 (9) · e92454-e92454

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have recently gained widespread use among patients with type 2 diabetes mellitus or obesity, owing to their substantial impact in lowering blood glucose levels and reducing body weight. Apart from this, the FDA Adverse Event Reporting System (FAERS) identified several dermatological side effects, including hair loss, associated with the administration of GLP-1 RAs, prompting further research. This systematic review aimed to provide a comprehensive and up-to-date overview of hair loss related to the use of GLP-1 RAs. The search strategy utilized PubMed, SCOPUS, and Web of Science databases using key terms: (("GLP-1 receptor agonist"[Mesh] OR "GLP1- receptor agonist"[tiab] OR "Glucagon-Like Peptide 1"[tiab] OR "GLP-1 agonist"[tiab] OR semaglutide[tiab] OR liraglutide[tiab] OR tirzepatide[tiab] OR exenatide[tiab] OR dulaglutide[tiab]) AND (hair loss[Mesh] OR alopecia[tiab] OR "telogen effluvium"[tiab] OR "alopecia areata"[tiab] OR hair[tiab]) ). Including all primary English studies, the hair loss outcomes associated with the use of GLP-1 RA in adults were reported without time restriction. A total of five relevant studies were included in this review, encompassing 2,905 adult patients who received subcutaneous trizepatide mainly on a weekly basis. The study yielded conflicting findings, with some indicating significant improvement and hair regrowth, while others reported hair loss as an adverse dermatological event. Further research is recommended to clarify the relationship between GLP-1 RAs and alopecia.

GLP-1 receptor agonistshair losstelogen effluviumalopecia areata
ReviewOpen (repository)202519citation· Semantic Scholar

Exploring Punicalagin Potential Against Cancers: A Comprehensive Review

Food Science & Nutrition · vol. 13 (3) · e70072-e70072

Punicalagin, being a bioactive polyphenol, has gained significant interest owing to its potential anticancer effects. Researchers are studying punicalagin to determine its ability to inhibit cancer cell proliferation. This paper focuses on highlighting the therapeutic potential of punicalagin against tumors and cancers. Punicalagin inhibits tumor growth within the body through various cellular pathway interactions. This compound effectively eliminates tumor cells from the liver, stomach, prostate, and lungs. Different animal model studies have demonstrated the potential of punicalagin in blocking the MAPK/ERK and PI3K/AKT/mTOR signaling pathways, fighting against cancer. Through the inhibition of cell division, punicalagin may be capable of eradicating breast cancer cells. Punicalagin strongly inhibits the activities of vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and uPA. Punicalagin effectively inhibits the androgen receptor (AR), a protein essential for the development and metastasis of prostate cancer. Lung cancer cells can be eliminated by initiating the caspase cascade and inhibiting protein synthesis, which is facilitated by punicalagin. In numerous animal models, punicalagin significantly reduces metastasis. Cyclokinase B1 and cyclin-dependent kinase 2 promote colon cancer; when colon cancer cells reach the G2/M phase, punicalagin induces apoptosis by inhibiting the action of these proteins. Punicalagin inhibits tumor development and cancer propagation by inhibiting blood vessel proliferation. There is still a need for further clinical trials and studies to fully reveal punicalagin's potential as well as its safety; despite the fact that it may decrease the threat of increasing tumors and provide an alternative treatment for many cancers.

punicalaginpolyphenolsanticancer activityERK signaling
ArticleClosed202519citation· Semantic Scholar

Integrated in Silico and in Vitro Studies of Rutin's Potential against SARS-CoV-2 through the Inhibition of the RNA-dependent RNA Polymerase

Current Medicinal Chemistry · vol. 32 (29) · 6353-6379

INTRODUCTION: In our quest to identify potent inhibitors against SARS-CoV-2, an extensive investigation was conducted for the binding and inhibitory efficacy of Rutin against nine SARS-CoV-2 proteins. METHODS: Structure Similarity, flexible alignment, Molecular Docking, molecular dynamics (MD) simulations and in vitro assays against the RdRp and SARS-CoV-2 have been conducted. RESULTS: The first step of our analysis involved a comprehensive examination of structural similarity among the co-crystallized ligands associated with those proteins. A substantial structural similarity was observed between Rutin and Remdesivir, the ligand of the SARS-CoV-2 RNAdependent RNA polymerase (RdRp). This similarity was validated through a flexible alignment study. Molecular docking studies, involving superimposition, revealed a notable resemblance in the mode of binding between Rutin and Remdesivir inside the active site of the RdRp. A 200 ns MD simulation confirmed that the RdRp-Rutin complex is more stable than the RdRp-Remdesivir complex. The MM-GBSA studies showed that Rutin had much more favorable binding energies, with a significantly lower value of -7.76 kcal/mol compared to Remdesivir's -2.15 kcal/mol. This indicates that the RdRp-Rutin binding is more robust and stable. PLIP and ProLIF studies helped clarify the 3D binding interactions and confirmed the stable binding seen in MD simulations. PCAT gave more insights into the dynamic behavior of the RdRp-Rutin complex. In vitro tests showed that Rutin has a strong inhibitory effect on RdRp with an IC50 of 60.09 nM, significantly outperforming Remdesivir, which has an IC50 of 24.56 μM. Remarkably, against SARS-CoV-2, Rutin showed a superior in vitro IC50 of 0.598 μg/ml compared to Remdesivir (12.47 μg/ml). The values of the selectivity index underscored the exceptional margin of safety of Rutin (SI: 1078) compared to Remdesivir (SI: 5.8). CONCLUSION: In conclusion, our comprehensive analysis indicates Rutin's promising potential as a potent SARS-CoV-2 RdRp inhibitor, providing a valuable insight for developing an effective COVID-19 treatment.

rutinSARS-CoV-2RNA-dependent RNA polymeraseRdRp inhibitors
ArticleOpen access202518citation· Semantic Scholar

Stearyl amine-modified elastic cerosomes for boosting the anti-cancer activity of albendazole

Frontiers in Pharmacology · vol. 16 · 1595177-1595177

Background Albendazole (ALB), originally developed as an anthelmintic agent, has been repurposed for use in cancer therapy. In the present work, ALB was incorporated into stearyl amine (SA)-based elastic cerosomes (EC) to improve its anticancer activity. Methods Stearyl amine elastic cerosomes containing albendazole (SA-EC-ALB) were formulated using the thin-film hydration method. A D-optimal experimental design was applied via Design-Expert® software (version 7) generating 19 formulations. The independent variables included SAA amount (X1), sonication time (X2), ceramide type (X3), and SAA type (X4), while the dependent variables were entrapment efficiency (EE%; Y1), particle size (PS; Y2), and polydispersity index (PDI; Y3). Results The optimized SA-EC-ALB formulation, prepared with ceramide III and Pluronic L121 through sonication, achieved an entrapment efficiency (EE%) of 92.03 ± 3.53% and a particle size (PS) of 312.05 ± 9.32 nm. In-silico analysis indicated strong interactions between ALB and the vesicular components in water. Moreover, in-vivo evaluation of SA-EC-ALB antitumor activity, performed using the solid Ehrlich tumor model in adult Swiss albino male mice, demonstrated a significant reduction in tumor volume compared to the control group. Conclusion Loading ALB into SA-EC could potentially induce its anticancer effects.

albendazoledrug delivery nanocarriersanticancer activitydrug repurposing
ArticleOpen access202518citation· Semantic Scholar

Novel deep reinforcement learning based collision avoidance approach for path planning of robots in unknown environment

PLoS ONE · vol. 20 (1) · e0312559-e0312559

Reinforcement learning is a remarkable aspect of the artificial intelligence field with many applications. Reinforcement learning facilitates learning new tasks based on action and reward principles. Motion planning addresses the navigation problem for robots. Current motion planning approaches lack support for automated, timely responses to the environment. The problem becomes worse in a complex environment cluttered with obstacles. Reinforcement learning can increase the capacity of robotic systems due to the reward system's capability and feedback to the environment. This could help deal with a complex environment. Existing algorithms for path planning are slow, computationally expensive, and less responsive to the environment, which causes late convergence to a solution. Furthermore, they are less efficient for task learning due to post-processing requirements. Reinforcement learning can address these issues using its action feedback and reward policies. This research presents a novel Q-learning-based reinforcement algorithm with deep learning integration. The proposed approach is evaluated in a narrow and cluttered passage environment. Further, improvements in the convergence of reinforcement learning-based motion planning and collision avoidance are addressed. The proposed approach's agent converged in 210th episodes in a cluttered environment and 400th episodes in a narrow passage environment. A state-of-the-art comparison shows that the proposed approach outperformed existing approaches based on the number of turns and convergence of the path by the planner.

collision avoidancerobot path planningdeep reinforcement learningQ-learning
ArticleOpen access202518citation· Semantic Scholar

Logical reasoning for human activity recognition based on multisource data from wearable device

Scientific Reports · vol. 15 (1) · 380-380

Smart wearable devices detection and recording of people's everyday activities is critical for health monitoring, helping persons with disabilities, and providing care for the elderly. Most of the research that is being conducted uses a machine learning-based methodology; however, these approaches frequently have issues with high computing resource consumption, burdensome training data gathering, and restricted scalability across many contexts. This research suggests a behaviour detection technology based on multi-source sensing and logical reasoning to address these problems. In order to realize the natural fusion of signal processing and logical reasoning in behavior recognition research, this work designs a lightweight behavior recognition solution using the pertinent theories of ontology reasoning in classical artificial intelligence. Machine learning technology is also employed for behavior recognition using the same data set. Once the best model has been chosen, the cross-person recognition results after testing and modification of parameters are 90.8% and 92.1%, respectively. This technology was used to create a behaviour recognition system, and several tests were run to assess how well it worked. The findings demonstrate that the suggested strategy achieves over 90% recognition accuracy for 11 different daily activities, including jogging, walking, and stair climbing. Additionally, the suggested strategy dramatically minimises the quantity of user-provided training data needed in comparison to machine learning-based behaviour identification techniques.

human activity recognitionwearable deviceslogical reasoningontology reasoning
ReviewOpen (repository)202517citation· Semantic Scholar

Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects

Food Science & Nutrition · vol. 13 (8) · e70727-e70727

The aura of the 21st century has been transformed due to a revolutionized health care system and modern industrial applications. However, human health and well-being are still a global challenge, affected by various metabolic and pathological morbidities, causing millions of mortalities. Cancer is one of the leading causes of fatalities globally, occurring due to pathogens, dietary factors, environmental toxins, occupational chemical exposure, and radiation. These factors lead to oxidative stress (OS), inflammation, DNA damage, epigenetic and genetic mutations, cell proliferation, tumorigenesis, and other chronic metabolic disorders such as diabetes mellitus, cardiovascular disorders, gastrointestinal problems, and hepato-renal syndrome. Among various types of cancers, lung cancer is leading them all, followed by breast and colorectal cancer (CRC). The oncogenesis includes activation of pro-inflammatory markers (IL-6, IL-1β, TNF-α), resulting in overexpression of oncogenes, downregulation of tumor suppressor genes (TSGs) like p53, pRb, APC, PTEN, suppression of antioxidant enzymes (GSH, CAT, SOD), and activation of signaling pathways (PI3K/Akt/mTOR/NF-κB, Ras/MAPK). However, plant-based herbal medicine is a valuable, affordable, and available management approach to reduce the risks of oncogenesis and other ailments. The bioactive compounds of these herbs make them an effective way to reduce inflammation, cancer, and the risk of other health problems. Eugenol (Eug), a volatile phenolic bioactive compound with a formula of C10H12O2, has been reported to have anticancer, antidiabetic, cardio- and pulmonary protective roles. Moreover, it can improve gut health and prevent neurodegenerative disorders. According to WHO, the safe dose of eugenol is 2.5 mg/kg for consumption. The current review focuses on the anticancer potential and other pharmacological aspects of eugenol through possible mechanisms.

eugenolanticancer activityoxidative stressinflammation
ArticleClosed202517citation· Semantic Scholar

Efficient Resource Management for NOMA- Enabled UAV Communications in 6G IRS-Assisted Vehicular Networks

IEEE Transactions on Intelligent Transportation Systems · vol. 27 (2) · 2706-2715

Intelligent reconfigurable surfaces (IRS) have emerged as a promising technology to enhance wireless communications by dynamically controlling the propagation environment. Despite their potential, practical challenges such as effective integration with existing systems and efficient optimization remain critical. This paper investigates the sum capacity enhancement of NOMA-enabled uncrewed aerial vehicle (UAV) communications in vehicular networks assisted IRS. In urban environments where direct links from UAV to vehicles are often obstructed by buildings or other obstacles, the IRS plays a critical role in improving signal quality by reflecting signals toward vehicles. We consider a downlink NOMA transmission scenario, where the UAV serves multiple ground vehicles, and signals are delivered through both direct and IRS-assisted links. A joint optimization problem is formulated to maximize the sum capacity by simultaneously optimizing UAV power allocation and IRS passive beamforming while ensuring a minimum signal-to-interference plus noise ratio requirement for each vehicle. To address the non-convex nature and reduce the complexity of the optimization, we first transform the original problem using the first-order Taylor expansion method. Then, we employ a two-step solution based on the fixed-point iteration method for passive beamforming at the IRS and standard convex optimization for UAV power allocation. The proposed solution is compared with a benchmark scheme with direct UAV-to-vehicle communication without IRS assistance. Numerical results demonstrate that our proposed framework converges quickly and significantly outperforms the benchmarks in terms of system capacity.

reconfigurable intelligent surfacenomaUAV communicationvehicular networks
ReviewOpen (repository)202516citation· Semantic Scholar

An Updated Review of the Anticancer Mechanisms and Therapeutic Potential of Naringenin

Food Science & Nutrition · vol. 13 (7) · e70626-e70626

The revolution in the 21st century has witnessed the development of the industrial and healthcare systems. Human health and well-being are still global challenges despite this modernization and advancement. Cancer is extensively affecting people, demanding special attention and an effective dietary approach. Bioactive compound-based natural therapies are a significant strategy to reduce the cancer burden. Naringenin, a bioactive compound widely distributed in the citrus family and is known for several health-promoting properties, including anticancer activity. The current review highlights the anticancer potential of Naringenin by exploring recent studies through various databases like Google Scholar, PubMed, ScienceDirect, and Web of Science. The analyses revealed that Naringenin can inhibit cell proliferation and oncogenesis through different molecular mechanisms and signaling pathways like apoptosis induction, cell cycle arrest, and modulation of P13K/AKT/mTOR, TGF-β1/Smad3, NF-κB, TLR4, and MAPK pathways. Moreover, it can inhibit inflammatory markers (IL-6, TNF-α, and IL-1β), downregulate oncogenes (Ras, HER2, MYC, and BCR/ABL1), and upregulate tumor suppressor genes (TSGs) such as TP53, PTEN, and BRCA1 and BRCA2 expression. Combining Naringenin with other bioactive compounds, chemotherapy drugs, and nanoformulations is a novel way to enhance its anticancer activity. However, poor bioavailability, stability, and lack of clinical trials and in silico studies hinder its therapeutic potential. Therefore, advanced techniques to enhance its stability and clinical trials regarding anticancer potential are required to validate its promising efficacy. The current review focuses on Naringenin's bioavailability, antioxidant, and anticancer potential through possible mechanisms.

naringenincitrus flavonoidsanticancer mechanismapoptosis induction
ArticleOpen access202516citation· Semantic Scholar

Enhancing pediatric congenital heart disease detection using customized 1D CNN algorithm and phonocardiogram signals

Heliyon · vol. 11 (3) · e42257-e42257

Congenital heart disease (CHD), impacting around 1 % of infants worldwide, constitutes a significant healthcare challenge. Early detection is crucial, however constrained by the intricacies of conventional diagnostic techniques such as auscultation and echocardiography. This research presents a tailored one-dimensional convolutional neural network (1D-CNN) for the classification of phonocardiogram (PCG) signals into normal or abnormal categories, providing an automated and efficient solution for congenital heart disease (CHD) diagnosis. The model was trained on a composite dataset consisting of local pediatric PCG signals and publicly accessible dataset. Preprocessing methods, such as low- and high-pass filtering (60-650 Hz), resampling, and noise reduction, were utilized to enhance signal quality. Data augmentation techniques, including chunking, padding, and pitch-shifting, were employed to rectify dataset imbalances and improve model efficacy. Experimental results indicate substantial enhancements, attaining an accuracy of 98.56 %, precision of 98.56 %, F1 score of 98.55 %, sensitivity of 0.98, and specificity of 0.99. The comparative analysis demonstrates the proposed approach's superiority over current methods regarding accuracy and reliability. The research highlights the promise of combining modern signal processing with deep learning for efficient CHD screening. The suggested model exhibits outstanding performance yet, issues like dataset variability and noise persist. Future endeavors involve extending to multiclass categorization and assessing performance across a wider range of medical problems. This study represents a significant advancement in accessible, automated CHD diagnoses, enhancing clinical competence to elevate pediatric treatment.

congenital heart diseasephonocardiogram1D convolutional neural networkpediatric cardiology